Drug developers are interested in innovative polymers and multilayer technology to help meet packaging requirements Read more
Equine polyclonal antibodies have shown higher potency in in-vitro studies of SARS-CoV-2 virus neutralisation Read more
Life sciences companies revisiting their EU strategies want to understand the Irish proposition better Read more
We are prepared to take on significant volumes from pharma partners working on COVID-19 vaccines Read more
To accelerate recovery of pharma ancillary industry, primary focus should be financial relief to players Read more